GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate-0.09-0.12-0.44-1.12
Low Estimate-0.09-0.12-0.44-1.12
High Estimate-0.09-0.12-0.44-1.12
Year Ago EPS-0.13-0.07-0.49-0.44
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.14-0.11-0.13-0.12
EPS Actual-0.13-0.07-0.12-0.11
Difference0.010.040.010.01
Surprise %7.10%36.40%7.70%8.30%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.09-0.12-0.44-1.12
7 Days Ago-0.09-0.12-0.44-1.12
30 Days Ago-0.09-0.12-0.44-1.12
60 Days Ago-0.1-0.12-0.45-1.12
90 Days Ago-0.12-0.12-0.46-1.06
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.30.80%N/AN/A0.48
Next Qtr.-71.40%N/AN/A0.40
Current Year10.20%N/AN/A0.21
Next Year-154.50%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A